Mobile clinic brings one-stop HIV and addiction care to those who inject drugs
NCT ID NCT04804072
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a mobile health unit that offers HIV prevention, treatment, and medication for opioid use disorder all in one place helps people who inject drugs stay on treatment. About 447 adults with opioid use disorder took part. The goal was to see if this approach increases use of HIV medicines and addiction treatment at 26 and 52 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bronx Prevention Center CRS
The Bronx, New York, 10451, United States
-
George Washington University CRS
Washington D.C., District of Columbia, 20007, United States
-
Houston AIDS Research Team CRS
Houston, Texas, 77030, United States
-
Penn Prevention CRS
Philadelphia, Pennsylvania, 19104, United States
-
UCLA Vine Street Clinic
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop anal lesions from becoming cancer?
- Can a new tool better measure opioid withdrawal?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?